AKEBIA THERAPEUTICS, INC. Revenues
AKEBIA THERAPEUTICS, INC. (AKBA) reported Revenues of $0 for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-09.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2016-11-09
- AKEBIA THERAPEUTICS, INC. revenues for the quarter ending 2016-09-30 was $0.00.
- AKEBIA THERAPEUTICS, INC. revenues for the quarter ending 2016-06-30 was $0.00.
- AKEBIA THERAPEUTICS, INC. revenues for the quarter ending 2016-03-31 was $0.00.
- AKEBIA THERAPEUTICS, INC. revenues for the quarter ending 2015-12-31 was $0.00.
- AKEBIA THERAPEUTICS, INC. revenues for fiscal 2015 was $0.00.
- AKEBIA THERAPEUTICS, INC. revenues for fiscal 2014 was $0.00.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $0.00 derived: sum of 2 quarters · filed 2016-11-09 | $0.00 10-Q · filed 2016-11-09 | $0.00 derived: sum of 4 quarters · filed 2016-11-09 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $0.00 10-Q · filed 2016-08-08 | $0.00 derived: sum of 3 quarters · filed 2016-08-08 | $0.00 derived: sum of 4 quarters · filed 2016-08-08 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-05 | $0.00 derived: sum of 2 quarters · filed 2016-05-05 | $0.00 derived: sum of 3 quarters · filed 2016-05-05 | $0.00 derived: sum of 4 quarters · filed 2016-05-05 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $0.00 derived: sum of 2 quarters · filed 2016-03-14 | $0.00 derived: sum of 3 quarters · filed 2016-03-14 | $0.00 10-K · filed 2016-03-14 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $0.00 derived: sum of 2 quarters · filed 2015-11-09 | $0.00 10-Q · filed 2015-11-09 | $0.00 derived: sum of 4 quarters · filed 2015-11-09 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | $0.00 10-Q · filed 2015-08-11 | $0.00 derived: sum of 3 quarters · filed 2015-08-11 | |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-11 | $0.00 derived: sum of 2 quarters · filed 2015-05-11 | ||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-04 | $0.00 10-K · filed 2015-03-04 | ||
| 2014-09-30 | $0.00 10-Q · filed 2014-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |